Home > About Sandostatin® LAR® > Sandostatin® LAR® Core Labeling Text
Sandostatin® LAR® Core Labeling Text
The Basic Prescribing Information (BPI) is the Novartis Core Data Sheet. It displays the company’s current position on important characteristics of the product, including the Core Safety Information according to ICH E2C.
National Prescribing Information is based on the BPI. However, because regulatory requirements and medical practices vary between countries, National Prescribing Information (incl. US Package Insert or European SPCs) may differ in several respects, including but not limited to the characterization of risks and benefits.
Disclaimer: This is an international website for Sandostatin® (Octreotide) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the US Residents link at the top of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.
